Artificial intelligence platform demonstrates promising results in effectively treating a patient with a rare cancer
In a first-of-its-kind clinical trial, a team leveraged an artificial intelligence-derived platform to guide treatment for a patient with a rare blood cancer.
In a first-of-its-kind clinical trial, a team leveraged an artificial intelligence-derived platform to guide treatment for a patient with a rare blood cancer.
